Victory Capital Management
AGRX

Victory Capital Management’s Agile Therapeutics AGRX Stock Holding History

Victory Capital Management’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7
Closed -$7K – 2851
2021
Q4 		$7K Buy
7
+1
+17% +$1.41K ﹤0.01% 2751
2021
Q3 		$11K Buy
6
+1
+20% +$2.26K ﹤0.01% 2756
2021
Q2 		$14K Hold
5
– – ﹤0.01% 2720
2021
Q1 		$23K Sell
5
-1
-17% -$5.41K ﹤0.01% 2715
2020
Q4 		$32K Buy
+6
New +$35.3K ﹤0.01% 2483
2020
Q3 		– Sell
-6
Closed -$31K – 2581
2020
Q2 		$31K Sell
6
-4
-40% -$20.8K ﹤0.01% 2424
2020
Q1 		$36K Buy
+10
New +$57.4K ﹤0.01% 2901
2019
Q4 		– Sell
-4
Closed -$10K – 3488
2019
Q3 		$10K Buy
+4
New +$9.85K ﹤0.01% 3277

Other funds holding AGRX

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return